Department of Osteopathic Medicine, Rowan School of Osteopathic Medicine, Stratford, New Jersey, USA
Review Article
Are We Stagnant at Managing Atherosclerosis? A Review
on Emergent Therapies in Treating Coronary Artery Disease
(CAD)
Author(s): Riddhi Machchhar*, Tasfia Tasnim and Carl Hock
Presently, Coronary Artery Disease (CAD) is medically managed to reduce cardiovascular morbidity and mortality, improve ischemic burden and maintain quality of life. Development of underlying atherosclerosis may be prevented via primordial prevention with risk management but once the inflammatory process of plaque formation initiates, there is a lack of therapeutic intervention in reversing this cascade. Conventional therapies include long-term pharmacologic management with aspirin and antiplatelet agents in reducing the risk of thrombosis. Furthermore, surgical management with coronary artery bypass graft and coronary artery stenting have shown efficacy in dec reasing mortality, yet the risk of restenosis is relatively high. This paper explores emerging therapies in surgical intervention, the use of nanotechnology, and pharmacological advancements in managing and somewhat reversing a.. Read More»
DOI:
10.37421/2329-9517.22.10.479
Cardiovascular Diseases & Diagnosis received 427 citations as per Google Scholar report